Outpatient Facility Coding Alert - 2006 Issue 33
COMPLIANCE: You Need To Tread Carefully When Billing For Part B Drugs
Subscribe or sign in to view the full article.
Article Overview
This compliance-focused article explains Medicare drug billing issues for physicians and medical practices. It covers allegations involving improper Part B drug billing, the distinction between drugs administered in the office versus taken home, and CMS guidance addressing drugs that may be covered under either Medicare Part B or Part D. The article is relevant to physicians, medical billers, coders, and compliance staff who handle Medicare claims and prescription-related documentation.
Why This Topic Matters
Misclassifying Medicare drug coverage or billing for drugs that were not administered in the office can lead to denied claims, audits, and repayment exposure. The article also highlights CMS guidance intended to reduce friction when a drug may be covered under either Part B or Part D, making it important for practices that manage Medicare prescriptions and claim submission.
What You Will Learn
- How Medicare Part B and Part D drug coverage can differ
- Why office administration documentation matters for Part B drug billing
- What kinds of Medicare drug billing disputes can trigger compliance concerns
- How CMS guidance addresses drugs that may be covered under either benefit
Who Should Read This
- Physicians
- Medical practice managers
- Medical billers
- Medical coders
- Compliance officers
- Revenue cycle staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com